Pulmonary Embolism: pathophysiology and the vital role of medical professionals
- Medics Anatomy
- Feb 25
- 2 min read
Pulmonary embolism (PE) is a potentially life-threatening condition that occurs when a blood clot, usually originating in the deep veins of the legs (deep vein thrombosis or DVT), travels to and lodges in the arteries of the lungs. It is imperative for healthcare professionals, particularly student paramedics, nurses, and other medical professionals, to have a comprehensive understanding of the pathophysiology, signs and symptoms, and treatment options for this condition. This article aims to provide a concise overview of PE to aid in its clinical practice.

Pathophysiology:
The pathophysiology of pulmonary embolism involves the obstruction of pulmonary arteries by blood clots. These clots most commonly originate from the deep veins of the lower extremities, but they can also arise from the pelvic veins, upper extremities, or right side of the heart. Risk factors for developing PE include immobility, surgery, trauma, obesity, smoking, pregnancy, oral contraceptive use, and a history of previous thromboembolic events.
Once a clot forms, it can dislodge and travel through the bloodstream until it reaches the pulmonary arteries. When the clot lodges in a vessel, it obstructs blood flow, causing impaired gas exchange and reduced oxygenation. Additionally, the clot triggers an inflammatory response and vasoconstriction, further compromising blood flow to the affected lung tissue.
Signs and Symptoms:
The signs and symptoms of pulmonary embolism can vary widely, making diagnosing it challenging. Some common manifestations include:
Sudden onset of dyspnoea (shortness of breath): This is the most prevalent symptom and is often accompanied by a sense of anxiety or impending doom.
Chest pain: Sharp, pleuritic chest pain worsened by deep breaths or coughing.
Tachypnoea: Rapid breathing due to the body's compensatory response to low oxygen levels.
Tachycardia: Increased heart rate to compensate for decreased cardiac output.
Cough: May be dry or produce bloody sputum.
Haemoptysis: Coughing up blood, which suggests more significant vessel involvement.
Syncope: Fainting or loss of consciousness may occur in severe cases.
It is important to note that not all patients will present with classic symptoms, especially those with chronic or subacute PE. Thus, a high index of suspicion is crucial when assessing patients with suspected pulmonary embolism.
Treatment:
Prompt and appropriate treatment is vital to improve patient outcomes with pulmonary embolism. The primary goals of treatment are to stabilise the patient, dissolve or remove the clot, and prevent further clot formation. The treatment modalities include:
Oxygen therapy: Administering supplemental oxygen to improve oxygenation and alleviate symptoms of hypoxemia.
Anticoagulation therapy: The immediate initiation of anticoagulant medications, such as heparin or low-molecular-weight heparin, to prevent the growth of existing clots and the formation of new ones.
Thrombolytic therapy: In severe cases of PE with hemodynamic instability, thrombolytic medications may be used to rapidly dissolve the clot.
Inferior vena cava (IVC) filter placement: For patients who cannot tolerate anticoagulation or who have recurrent embolism despite anticoagulant therapy, an IVC filter may be inserted to prevent large clots from reaching the pulmonary arteries.
Embolectomy or thrombectomy: When the patient's condition is critical or thrombolytic therapy is contraindicated, surgical removal of the clot may be necessary.
Pulmonary embolism is a serious and potentially life-threatening condition that requires swift recognition and intervention by healthcare professionals. Understanding the pathophysiology, recognising the signs and symptoms, and implementing appropriate treatment strategies are essential for student paramedics, nurses, and other medical professionals.



